I've been following this biotech for a long long time. The just did a secondary to get themselves through a phase 2 trial, but by the looks of it, I believe this one will be fast tracked. Really do some DD on this one because I think this is the real deal. Resistance is at 5.50 and if it gets through that I think we could see some real momentum higher.